Atlas Bio
In silico clinical trials in immunology, powered by a foundation AI model of human biology
O firmie Atlas Bio
Atlas Bio (Atlas Bio AG) is a Basel-based startup founded in 2024 that runs in silico clinical trials in immunology. Its foundation AI model of human biology, trained on around two million human tissue RNA readouts, predicts patient-level efficacy and safety responses across treatments and indications. Biopharma teams use the predictions to decide which assets to advance, acquire or expand, to compare mechanisms with standard of care and to find responder biomarkers before Phase II. It is based at Switzerland Innovation Park Basel Area on the Novartis Campus.
Założyciele
Sebastian Bayer
Co-founder & CTO
Simon Romanski
Co-founder & CEO
- Biotech & Life Sciences
- Basel, Szwajcaria
- Seed
- 2024
Rundy finansowania
| Data | Runda | Kwota | Główni inwestorzy |
|---|---|---|---|
| Seed | Nieujawniona | Creandum | |
| — | Pre-seed | Nieujawniona | First Momentum Ventures, LEA Partners |
